These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5540731)

  • 21. [Considerations on auricular senescence].
    Vaska B
    Otorinolaringologie; 1967; 12(2):139-46. PubMed ID: 4227706
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of nicotinic acid, vitamins A, B12 and E on the lysis of intravascular thrombi in experimental animals].
    Byshevskiĭ ASh
    Vrach Delo; 1966 Jan; 1():38-40. PubMed ID: 5974055
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies with the computer-guided perimeter "Peritest" on the effect of Cosaldon A+E on glaucomatous visual field defects].
    Stark H
    Ophthalmologica; 1985; 191(4):238-49. PubMed ID: 4088612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic use of combined vitamin A, vitamin E and nicotinic acid in chronic progressive deafness and in diseases of the inner ear.
    ROSSI G
    Riforma Med; 1955 Apr; 69(16):Suppl, 1-4. PubMed ID: 14385650
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the drug therapy of old-age hearing disorders].
    Kroath F
    Monatsschr Ohrenheilkd Laryngorhinol; 1967; 101(8):395-400. PubMed ID: 4174077
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of auditory perception disorders using complamine].
    Kuniak B; Bargár Z
    Cesk Otolaryngol; 1974 Oct; 23(5):285-8. PubMed ID: 4452113
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic use of combined vitamin A, vitamin E and nicotinic acid in progressive chronic deafness and in pathology of the inner ear.
    ROSSI G
    Minerva Otorinolaringol; 1955; 5(4):261-5. PubMed ID: 13279824
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic use of associated vitamin A, vitamin E and nicotinic acid in progressive chronic deafness and in pathology of the inner ear].
    ROSSI G
    Riforma Med; 1955 Feb; 69(6):164a-d. PubMed ID: 14372793
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of acute and chronic circulatory disorders with special reference to complamine].
    Athitakis KN
    Med Monatsschr; 1966 Sep; 20(9):428-30. PubMed ID: 5975343
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical studies on Juston].
    Bornfleth GH; Lehrach F
    Med Monatsschr; 1975 Jan; 29(1):22-4. PubMed ID: 1091842
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of senile macular degeneration. Results of a multicenter study].
    Sartori C; Marx-Heep I
    ZFA (Stuttgart); 1982 Aug; 58(22):1206-10. PubMed ID: 6753394
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experiences with Juston in patients with depressive and dystonic disorders].
    Seitz H
    Ther Ggw; 1976 Sep; 115(9):1566-72. PubMed ID: 788216
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of cardiac and cerebrovascular insufficiency with Card-Cosaldon. Result of a field study].
    Koeppen G; Schmidt-Modrow G
    Ther Ggw; 1979 Nov; 118(11):1704-13. PubMed ID: 538738
    [No Abstract]   [Full Text] [Related]  

  • 34. [Resignation--a problem of advanced age? Treatment of psychogenic and somatogenic geriatric complaints].
    Ofenstein C
    Z Allgemeinmed; 1975 May; 51(15):721-3. PubMed ID: 1096481
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experiences with alpha-tocopherol micotinate in the treatment of arteriosclerosis].
    Dobrowolski L
    Fortschr Med; 1972 Sep; 90(25):913-6. PubMed ID: 4642946
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
    Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
    Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental investigations on drug induced improvement of brain metabolism].
    Köhler W
    Wien Klin Wochenschr; 1972 May; 84(21):340-3. PubMed ID: 5064086
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of fibrinolysis activation on the peripheral blood circulation in occlusive vascular diseases].
    Bielawiec M; Lukjan H
    Med Monatsschr; 1971 Jul; 25(7):312-4. PubMed ID: 5563915
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study on medical therapy of various forms of deafness with a vitamin A and E combination (rovigon)].
    WEDER A; MISSURA T
    Pract Otorhinolaryngol (Basel); 1959 Jan; 21(1):55-78. PubMed ID: 13623573
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of nicotinic acid on cerebral and peripheral blood supply in attacks (rheoencephalographic and oscillographic studies)].
    Hadjiev D
    Psychiatr Neurol Med Psychol (Leipz); 1965 Aug; 17(8):291-6. PubMed ID: 5847589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.